Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Location contact
Ahmad Parvinian, MD
PRINCIPAL_INVESTIGATOR
Clinical Trials Referral Office
CONTACT
NCT Number: NCT07720102
This study evaluates satisfaction with percutaneous ablation and any symptoms experienced before and after the procedure in patients with lung tumors.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Rochester, Minnesota, 55905, United States
Ahmad Parvinian, MD
PRINCIPAL_INVESTIGATOR
Clinical Trials Referral Office
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Non-interventional study
Other names: Non-Interventional Observational Study, Noninterventional (Observational) Study
Time frame: Baseline (prior to ablation), 1 day, 3 days, 7 days, 1 month, 3 months
Assessed using a study-specific survey. Participants evaluate 5 symptoms (pain, fatigue, drowsiness, shortness of breath, and disturbed sleep), each on an 11-point Likert scale of 0-10 where 0=absence of symptoms and 10=as bas as you can imagine. Higher scores indicate greater severity of symptoms.
Contact information is provided by the study sponsor or research team.
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06024538
Cancer Associated Fibroblast, Lung Diseases
Bordeaux, France
View Trial DetailsNCT05676788
Lung Diseases, Lung Neoplasm
Großhansdorf, Germany
View Trial DetailsNCT07632664
Aged, Lung Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT06780098
Lung Diseases, Lung Neoplasm
Lexington, Kentucky, United States
View Trial Details